No dignity in euthanasia

Function getAdCookie(name) { var regex = new RegExp(name + "=(.*?)(; |&|$)", "gi"); var value = regex.exec(document.cookie); if (value && value.length == 3) { value = value[1]; } else { value = ""; } return value; } function getFrameDocument(fr) { var doc = fr.contentWindow || fr.contentDocument; if (doc && doc.document) { doc = doc.document; } return doc; } function closeDoc(doc) { doc.close(); } function isIE() { return /msie/i.test(navigator.userAgent) && !/opera/i.test(navigator.userAgent); } function setHash (element, hash) { if(element.hash) { element.hash = element.hash + "," + hash; } else { element.hash = hash; } } function renderIFAd(holderID, adID, srcUrl, width, height, hash) { setHash(document.getElementById(holderID), hash); document.dcdAdsR.push(adID); document.

Ischaemic Heart Disease - News


No dignity in euthanasia
No dignity in euthanasia

I am chronically ill with a progressive rheumatoid auto-immune disease that destroyed my kidneys and causes inflammation around the lungs, inner chest walls and heart, ischaemic heart disease and peripheral neuropathy. I have been dependent on dialysis



Hundreds treated for heart disease every year

Over 400 patients, he said come into the EWMSC every year to be treated for heart diseases. These include, he said, adults and children. According to Dr Rampersad, one of the most common types of heart disease is ischaemic heart disease also known as



Controlling CV risk in CKD patients
Controlling CV risk in CKD patients

Hypertension is associated not only with coronary disease but also ischaemic heart disease and heart failure. Later, once the kidneys start to fail, other abnormalities may be as important. Anaemia and mineral bone disease, which occur late in the CKD



Low Serum Cholesterol Level and Increased Ischemic Stroke Mortality

LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population: the Hisayama study. Stroke. 2009;40(2):382-388. FREE FULL TEXT 3. Yokota C, Minematsu K, Hasegawa Y, Yamaguchi T. Long-term prognosis,



Protein holds key to mending a damaged heart, but only in mice…

This may help to reduce the risk of ischaemic heart disease in men over the age of 40 and women after the menopause. Eat a balanced diet. Base your meals on starchy foods with some dairy and non-dairy sources of protein, and plenty of fruit and




Increase Cardiovascular Risk in Older Diabetics With Use of ...

By: Jill Stein

SAN DIEGO, CA – Older patients with type 2 diabetes who are prescribed a sulphonylurea drug have a significantly higher risk of a cardiovascular event within 2 years than older type 2 diabetics who are prescribed metformin, according to data presented at the 71st Scientific Sessions of the American Diabetes Association.

The findings are drawn from a retrospective study that examined data from the electronic health records of 8,656 type 2 patients who were 65 years of age or older.

“The results are important because sulphonylurea drugs are commonly prescribed to older diabetic patients to lower glucose levels and cardiovascular [disease] is the leading cause of death in type 2 diabetic patients,” said Alex Z. Fu, PhD, Cleveland Clinic, Cleveland, Ohio.

All patients had received a first prescription for antihyperglycaemic therapy between 2003 and 2008 and had remained on their prescribed therapy for at least 90 days.

The 2 treatment groups were similar with respect to demographic and clinical characteristics after matching.

Overall, 14.8% of patients who initiated therapy with a sulphonylurea had a cardiovascular disease event (ischaemic heart disease, myocardial infarction, stroke, transient ischaemic attack, peripheral arterial disease, and congestive heart failure) after 2 years of follow-up versus 11.6% of patients who initiated treatment with metformin. The difference between the 2 groups was primarily due to the increased incidence of ischaemic heart disease with a sulphonylurea (7.1%) compared with metformin (5.3%), and congestive heart failure with a sulphonylurea (3.4%) versus metformin (1.9%).

The likelihood of having a cardiovascular event was higher in patients who started treatment with a sulphonylurea than in patients who started treatment with metformin (OR = 1.33; 95% CI, 1.17-1.


Twitter

Edith Arpin ;) copd life expectancy [EQ] Altitude, life expectancy and mortality from ischaemic heart disease, stroke, COPD and ...


Kimbery Lyons copd life expectancy [EQ] Altitude, life expectancy and mortality from ischaemic heart disease, stroke, COPD and ...


Vladimir Kosik Signs and Symptoms of Ischaemic Heart Disease


Ischaemic Heart Disease - Bookshelf

Ischaemic heart disease

Ischaemic heart disease


Ischaemic heart disease

Ischaemic heart disease


Ischaemic heart disease, the strategy of postponement

Ischaemic heart disease, the strategy of postponement


Ischaemic heart disease, therapeutic issues

Ischaemic heart disease, therapeutic issues


Ischaemic heart disease, the strategy of postponement

Ischaemic heart disease, the strategy of postponement


Find An Article Directory


Ischaemic heart disease - Wikipedia, the free encyclopedia
Ischaemic or ischemic heart disease (IHD), or myocardial ischaemia, ... Symptoms of stable ischaemic heart disease include angina (characteristic chest pain on exertion) and ...

Ischaemic Heart Disease
Ischaemic heart disease arises when the heart is not adequately provided with blood ... Heart failure may occur because of ischaemic heart disease. ...

Ischaemic Heart Disease – Prognosis, Signs And Symptoms
Ischaemic Heart Disease is a coronary heart disease that restricts the blood flow and damages the heart muscles. Read this article for a quick review ...

Ischaemic heart disease - WrongDiagnosis.com
Ischaemic heart disease symptoms, causes, diagnosis, and treatment information for Ischaemic heart disease (Ischemic heart disease) with alternative ...

Ischaemic heart disease
Ischaemic (or ischemic) heart disease is a disease characterized by reduced blood supply to the heart. It is the most common cause of death in most ...